Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2018

Segment Reporting [Abstract]

Schedule of Segment Information

The tables below present segment information reconciled to total Company loss from operations, with segment operating loss including gross profit less direct research and development expenses and direct selling, general and administrative expenses to the extent specifically identified by segment:

	Three Months Ended September 30, 2018
	Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues	$	1,724,000		$	-		$	1,724,000
Gross margin		952,000			-			952,000
Total operating expenses		(1,159,000	)		(304,000	)		(1,463,000	)
Loss from operations	$	(207,000	)	$	(304,000	)	$	(511,000	)

	Nine Months Ended September 30, 2018
	Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues	$	4,075,000		$	-		$	4,075,000
Gross margin		2,249,000			-			2,249,000
Total operating expenses		(4,019,000	)		(517,000	)		(4,536,000	)
Loss from operations	$	(1,770,000	)	$	(517,000	)	$	(2,287,000	)

	Three Months Ended September 30, 2017
	Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues	$	916,000		$	-		$	916,000
Gross margin		532,000			-			532,000
Total operating expenses		(1,034,000	)		(16,000	)		(1,050,000	)
Loss from operations	$	(502,000	)	$	(16,000	)	$	(518,000	)

	Nine Months Ended September 30, 2017
	Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues	$	2,509,000		$	-		$	2,509,000
Gross margin		1,504,000			-			1,504,000
Total operating expenses		(3,311,000	)		(16,000	)		(3,327,000	)
Loss from operations	$	(1,807,000	)	$	(16,000	)	$	(1,823,000	)